Lataa...
Was phenserine a failure or were investigators mislead by methods?
Over 200 Alzheimer’s disease (AD) drug candidates have failed in development, and other neuropsychiatric trials have had their validity compromised. Studies suggest that methodological errors can be a source for these compromises and failures. We gained access to documentation for phenserine, an exp...
Tallennettuna:
| Julkaisussa: | Curr Alzheimer Res |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5182048/ https://ncbi.nlm.nih.gov/pubmed/23227991 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|